HIT-HARD Trial Protocol Tests Short-Course High-Dose Antibiotics
The HIT-HARD trial protocol outlines a phase III study testing if short-course, high-dose beta-lactam therapy is non-inferior to conventional regimens ...
The HIT-HARD trial protocol outlines a phase III study testing if short-course, high-dose beta-lactam therapy is non-inferior to conventional regimens ...
A multicentre randomised trial is testing whether an oral bacterial lysate can reduce recurrent wheezing episodes in infants following hospitalisation ...
A phase II multicentre study protocol evaluates the feasibility of combining neoadjuvant intraperitoneal irinotecan with systemic therapy prior to cytoreductive ...
A multicenter clinical trial protocol outlines a randomized factorial study evaluating whether transcutaneous electrical acupoint stimulation at the P6 acupoint ...
A new trial protocol in the Basque Health Service plans to test if pharmacist-led facilitation can enhance audit and feedback ...
A new phase 2a trial protocol aims to evaluate the pharmacokinetics and safety of empagliflozin in children with Duchenne muscular ...
A randomized controlled trial in Ireland will test whether a high-fibre, fermented-food diet targeting the gut microbiota can reduce ADHD ...
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults ...
A new phase II trial protocol will test whether AGuIX nanoparticles, already shown to be tolerated at 100 mg/kg in ...
A published protocol details the first randomised, placebo-controlled trial testing whether the oral drug PXS-4728A reduces PET-measured brain neuroinflammation in ...
The DSEE-CRC trial will randomize patients with chemotherapy-refractory metastatic colorectal cancer to tumoroid-guided therapy or standard trifluridine-tipiracil and bevacizumab.
A new Canadian protocol study will test whether children aged 6 to 17 can complete and tolerate a ten-minute virtual ...
The French PSMA-PRED protocol plans to profile tumor DNA, RNA and methylation in 120 patients to identify candidate biomarkers associated ...
A planned 90-patient randomized trial will compare cilastatin with sodium thiosulfate for preventing acute kidney injury during cisplatin-based HIPEC, but ...
A 130-participant assessor-blinded trial in Tianjin will compare penetrating needling between two ankle acupoints with separate needling at the same ...
A planned multicenter trial will randomize 262 postoperative breast cancer survivors to Shenqi Shiyiwei Granule or placebo to test a ...
The BELI(E)VE protocol describes a German phase I/IIa trial of belantamab mafodotin plus venetoclax, with or without dexamethasone, in t(11;14)-positive ...
A new nationwide Australian study will follow people with inherited pancreatic cancer risk for up to ten years to determine ...
A twelve-hospital, double-blind, placebo-controlled trial in China will test whether the traditional herbal formula Yiqi Huayu Jiedu Decoction combined with ...
In a groundbreaking advancement poised to transform our understanding of medication safety during breastfeeding, researchers at Uppsala University, Sweden, are ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.